The Business Cocktail

FDA declines the approval of Lipocine’s testosterone drug; Novartis Sandoz to buy Aspen Pharmacare Japanese Unit

Business Consultant, DelveInsight's Drug Report, Notizia, Pharma Consultant, The Business Cocktail

The US FDA for the third time has refused to give approval to Lipocine’s oral testosterone drug, Tlando. The drug is an oral testosterone...

Read More

FDA approval to AZ’s Farxiga for heart failure; GSK divests two travel vaccines to Bavarian Nordic; New breakthrough therapy for Cystic Fibrosis

Business Consultant, DelveInsight's Drug Report, Notizia, Pharma Consultant, The Business Cocktail

The US FDA today has given its nod to Trikafta (elexacaftor/ivacaftor/tezacaftor) of Vertex Pharmaceuticals, the first of its kind triple...

Read More
Close